API Development Services

Our API development services begin with innovative route design, offering both proprietary and non-infringing pathways for complex and simple molecules. We focus on cost efficiency, scalability, and intellectual property protection, ensuring your molecule is developed with a commercially viable and regulatory-compliant approach from the earliest stages of development.

We deliver robust process development using DOE and QbD principles to ensure efficiency, consistency, and scalability. From laboratory research to pilot-scale production, our team focuses on impurity profiling, cost control, and process robustness, enabling a smooth transition to clinical and commercial manufacturing with reduced risks and improved reliability.

Our analytical development expertise covers method design, validation, and stability studies in line with ICH guidelines. We specialize in impurity identification, structural characterization, and polymorph screening to generate reliable data. This ensures product safety, regulatory compliance, and consistent quality throughout your molecule’s development and lifecycle.

We provide end-to-end regulatory documentation support, including USDMF, CTD, and global dossier preparation. Our experienced team ensures submissions are comprehensive, accurate, and aligned with international requirements, reducing approval timelines. With strong technical and regulatory expertise, we help accelerate market entry and maintain compliance across global health authorities.

With specialized facilities and strict containment protocols, we offer safe and efficient development of Highly Potent APIs (HPAPIs). Our OEB/OEL-controlled environments protect both personnel and product integrity. These advanced capabilities make us a trusted partner for oncology and other therapeutic areas requiring high-potency molecule development.

We ensure successful technology transfer through detailed tech packs, robust data integrity, and well-documented processes. Our structured approach minimizes variability and supports seamless scale-up from lab to clinical and commercial production. This readiness enables faster timelines, consistent outcomes, and smooth collaboration with global manufacturing partners.